Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-26

FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approves a supplemental application to market ADVIL ALLERGY AND CONGESTION RELIEF, a fixed-dose combination product containing chlorpheniramine maleate, ibu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL ALLERGY AND CONGESTION RELIEF

Snippet

SUPPL AP for ADVIL ALLERGY AND CONGESTION RELIEF (CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE)